Back to search
Chronic Idiopathic Pruritus
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Chronic Idiopathic Pruritus trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Chronic Idiopathic Pruritus trials you may qualify forThe primary objective of this study is to assess the PK/PD relationship of nemolizumab in adult participants aged 18 years or above with chronic pruritus of unk…
The main objective of the study is to assess efficacy and safety of dupilumab given up to 24 weeks in adults with CPUO. This is a master protocol which include…
Chronic idiopathic pruritus (CIP) is a frequent and disabling condition, for which there is no specific treatment. It was shown previously that hypnosis can rel…
This study is being conducted to evaluate the efficacy and safety of povorcitinib in adults with CSU that is inadequately controlled using SOC treatments.
Participants with diseases characterized by chronic pruritus experiencing moderate to severe pruritus will be enrolled in this pilot Phase 2 study. The disease…